OrbiMed Advisors as of June 30, 2011
Portfolio Holdings for OrbiMed Advisors
OrbiMed Advisors holds 100 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corp note 4.750%10/0 | 32.9 | $1.8B | 7.7M | 229.76 | |
| CUBIST PHARM CONVERTIBLE security | 5.2 | $281M | 2.0M | 140.36 | |
| Volcano Corporation note 2.875% 9/0 | 3.5 | $187M | 1.5M | 124.36 | |
| Gilead Sciences (GILD) | 2.6 | $143M | 3.5M | 41.41 | |
| Bristol Myers Squibb (BMY) | 2.6 | $142M | 4.9M | 28.96 | |
| WellPoint | 2.6 | $142M | 1.8M | 78.77 | |
| Pfizer (PFE) | 2.6 | $139M | 6.7M | 20.60 | |
| Allergan | 2.4 | $127M | 1.5M | 83.25 | |
| Shire | 1.7 | $90M | 955k | 94.21 | |
| UnitedHealth (UNH) | 1.5 | $79M | 1.5M | 51.58 | |
| Merck & Co (MRK) | 1.4 | $77M | 2.2M | 35.29 | |
| Warner Chilcott Plc - | 1.4 | $76M | 3.1M | 24.13 | |
| Johnson & Johnson (JNJ) | 1.3 | $72M | 1.1M | 66.52 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $72M | 2.6M | 27.21 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $70M | 1.1M | 64.39 | |
| Express Scripts | 1.3 | $71M | 1.3M | 53.98 | |
| Pharmasset | 1.3 | $68M | 607k | 112.20 | |
| Incyte Corporation (INCY) | 1.2 | $67M | 3.5M | 18.94 | |
| Watson Pharmaceuticals | 1.2 | $64M | 927k | 68.73 | |
| Complete Genomics | 1.2 | $64M | 4.2M | 15.28 | |
| Illumina (ILMN) | 1.1 | $61M | 810k | 75.15 | |
| Pharmacyclics | 1.1 | $60M | 5.8M | 10.44 | |
| Life Technologies | 1.1 | $58M | 1.1M | 52.07 | |
| NxStage Medical | 1.1 | $57M | 2.7M | 20.82 | |
| Medtronic | 1.0 | $55M | 1.4M | 38.53 | |
| Humana (HUM) | 1.0 | $55M | 680k | 80.54 | |
| CIGNA Corporation | 0.9 | $51M | 998k | 51.43 | |
| Elan Corporation | 0.9 | $51M | 4.5M | 11.37 | |
| Human Genome Sciences | 0.9 | $49M | 2.0M | 24.54 | |
| Zimmer Holdings (ZBH) | 0.7 | $38M | 595k | 63.20 | |
| NPS Pharmaceuticals | 0.7 | $38M | 4.0M | 9.45 | |
| Mylan | 0.7 | $36M | 1.5M | 24.67 | |
| Affymetrix | 0.7 | $35M | 4.4M | 7.93 | |
| Perrigo Company | 0.7 | $35M | 396k | 87.87 | |
| Sequenom | 0.7 | $35M | 4.6M | 7.55 | |
| Baxter International (BAX) | 0.6 | $34M | 568k | 59.69 | |
| Pacira Pharmaceuticals (PCRX) | 0.6 | $34M | 2.8M | 12.00 | |
| Insulet Corporation (PODD) | 0.6 | $32M | 1.5M | 22.17 | |
| Hospira | 0.5 | $29M | 510k | 56.66 | |
| Aetna | 0.5 | $29M | 648k | 44.09 | |
| 3SBio (SSRX) | 0.5 | $28M | 1.6M | 17.43 | |
| EXACT Sciences Corporation (EXAS) | 0.5 | $27M | 3.1M | 8.60 | |
| Vivus | 0.5 | $26M | 3.2M | 8.14 | |
| Amarin Corporation | 0.5 | $26M | 1.8M | 14.43 | |
| McKesson Corporation (MCK) | 0.5 | $26M | 308k | 83.65 | |
| MAP Pharmaceuticals | 0.5 | $25M | 1.6M | 15.97 | |
| Anthera Pharmaceuticals | 0.5 | $25M | 3.0M | 8.17 | |
| Stryker Corporation (SYK) | 0.4 | $24M | 401k | 58.69 | |
| Align Technology (ALGN) | 0.4 | $24M | 1.0M | 22.80 | |
| Forest Laboratories | 0.4 | $23M | 578k | 39.34 | |
| Celgene Corporation | 0.4 | $22M | 358k | 60.32 | |
| Allos Therapeutics | 0.4 | $21M | 9.7M | 2.14 | |
| Valeant Pharmaceuticals Int | 0.4 | $21M | 398k | 51.96 | |
| Cardinal Health (CAH) | 0.4 | $20M | 437k | 45.42 | |
| Biogen Idec (BIIB) | 0.4 | $20M | 186k | 106.92 | |
| Antares Pharma | 0.4 | $20M | 9.0M | 2.21 | |
| Hca Holdings (HCA) | 0.4 | $20M | 596k | 33.00 | |
| Given Imaging | 0.3 | $18M | 905k | 20.35 | |
| OraSure Technologies (OSUR) | 0.3 | $19M | 2.2M | 8.53 | |
| Affymax (AFFY) | 0.3 | $18M | 2.5M | 6.87 | |
| K-V Pharmaceutical Company | 0.3 | $17M | 6.4M | 2.72 | |
| Medivation | 0.3 | $15M | 713k | 21.43 | |
| Idenix Pharmaceuticals | 0.2 | $14M | 2.7M | 5.00 | |
| Oncothyreon | 0.2 | $13M | 1.4M | 9.19 | |
| CareFusion Corporation | 0.2 | $12M | 434k | 27.17 | |
| ArQule | 0.2 | $12M | 1.9M | 6.25 | |
| Inhibitex | 0.2 | $11M | 2.8M | 3.92 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $11M | 649k | 16.77 | |
| Onyx Pharmaceuticals | 0.2 | $9.9M | 280k | 35.30 | |
| Volcano Corporation | 0.2 | $8.4M | 260k | 32.29 | |
| Boston Scientific Corporation (BSX) | 0.1 | $8.3M | 1.2M | 6.91 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $8.0M | 157k | 51.11 | |
| Alexion Pharmaceuticals | 0.1 | $8.1M | 171k | 47.03 | |
| InterMune | 0.1 | $7.2M | 201k | 35.85 | |
| Targacept | 0.1 | $7.2M | 342k | 21.07 | |
| Covidien | 0.1 | $6.9M | 130k | 53.23 | |
| Cubist Pharmaceuticals | 0.1 | $5.8M | 163k | 35.98 | |
| DaVita (DVA) | 0.1 | $5.6M | 65k | 86.62 | |
| Uroplasty | 0.1 | $5.4M | 725k | 7.50 | |
| Anadys Pharmaceuticals (ANDS) | 0.1 | $5.4M | 5.3M | 1.02 | |
| Biodel | 0.1 | $5.6M | 3.0M | 1.87 | |
| Hologic (HOLX) | 0.1 | $5.0M | 250k | 20.17 | |
| Regeneron Pharmaceuticals (REGN) | 0.1 | $4.4M | 77k | 56.71 | |
| Medco Health Solutions | 0.1 | $4.1M | 73k | 56.52 | |
| Edwards Lifesciences (EW) | 0.1 | $4.4M | 50k | 87.18 | |
| Amgen (AMGN) | 0.1 | $4.3M | 74k | 58.34 | |
| Syneron Medical Ltd ord | 0.1 | $4.4M | 364k | 12.13 | |
| Quest Diagnostics Incorporated (DGX) | 0.1 | $4.3M | 73k | 59.10 | |
| Athersys | 0.1 | $4.4M | 1.6M | 2.71 | |
| Insmed (INSM) | 0.1 | $4.1M | 341k | 11.99 | |
| Trius Therapeutics | 0.1 | $3.6M | 450k | 7.92 | |
| Sanofi Aventis Wi Conval Rt | 0.1 | $3.8M | 1.6M | 2.41 | |
| United Therapeutics Corporation (UTHR) | 0.1 | $3.5M | 63k | 55.10 | |
| Pacific Biosciences of California (PACB) | 0.1 | $3.3M | 282k | 11.70 | |
| Covance | 0.1 | $2.9M | 48k | 59.38 | |
| D Tranzyme | 0.1 | $2.9M | 700k | 4.18 | |
| Questcor Pharmaceuticals | 0.0 | $2.4M | 100k | 24.10 | |
| Cynosure | 0.0 | $2.2M | 180k | 12.10 | |
| Solta Medical | 0.0 | $1.4M | 493k | 2.76 | |
| Orexigen Therapeutics | 0.0 | $318k | 200k | 1.59 |
